These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

997 related items for PubMed ID: 10648117

  • 1. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K, Burack L, Pope M, Krueger JG, Austin LM.
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [Abstract] [Full Text] [Related]

  • 2. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD, Starling GC, Williams LA, Hock BD, Hart DN.
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [Abstract] [Full Text] [Related]

  • 3. Persistent CMV infection correlates with disease activity and dominates the phenotype of peripheral CD8+ T cells in psoriasis.
    Weitz M, Kiessling C, Friedrich M, Prösch S, Höflich C, Kern F, Volk HD, Sterry W, Asadullah K, Döcke WD.
    Exp Dermatol; 2011 Jul; 20(7):561-7. PubMed ID: 21410770
    [Abstract] [Full Text] [Related]

  • 4. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B, Nash MA, Lenzi R, Platsoucas CD, Freedman RS.
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.
    Manzotti CN, Tipping H, Perry LC, Mead KI, Blair PJ, Zheng Y, Sansom DM.
    Eur J Immunol; 2002 Oct; 32(10):2888-96. PubMed ID: 12355442
    [Abstract] [Full Text] [Related]

  • 6. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S, Maiti PK, Nandi D.
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K, Głowacka E, Kulig A, Lewy-Trenda I, Bryś M, Lewkowicz P.
    Folia Histochem Cytobiol; 2011 Nov; 49(4):579-92. PubMed ID: 22252752
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D, Wyss-Coray T, Gallati H, Pichler WJ.
    J Immunol; 1995 Jul 01; 155(1):118-27. PubMed ID: 7541409
    [Abstract] [Full Text] [Related]

  • 11. Dysregulated expression of CD69 and IL-2 receptor alpha and beta chains on CD8+ T lymphocytes in flaky skin mice.
    Abernethy NJ, Hagan C, Tan PL, Watson JD.
    Immunol Cell Biol; 2000 Dec 01; 78(6):596-602. PubMed ID: 11114969
    [Abstract] [Full Text] [Related]

  • 12. Does immune activation continue during an attack-free period in familial Mediterranean fever?
    Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY, Inal A, Tuzun A, Erdil A, Bagci S.
    Clin Exp Immunol; 2004 Dec 01; 138(3):526-33. PubMed ID: 15544632
    [Abstract] [Full Text] [Related]

  • 13. Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease.
    Baker C, Chang L, Elsegood KA, Bishop AJ, Gannon DH, Narendran P, Leech NJ, Dayan CM.
    Clin Exp Immunol; 2007 Mar 01; 147(3):472-82. PubMed ID: 17302896
    [Abstract] [Full Text] [Related]

  • 14. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ, Seyger MM, Van de Kerkhof PC.
    Br J Dermatol; 2005 Jul 01; 153(1):72-8. PubMed ID: 16029329
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
    Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ.
    J Immunol; 1995 Mar 15; 154(6):2668-77. PubMed ID: 7533180
    [Abstract] [Full Text] [Related]

  • 17. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
    Gessl A, Waldhäusl W.
    J Clin Endocrinol Metab; 1998 Jun 15; 83(6):2204-9. PubMed ID: 9626161
    [Abstract] [Full Text] [Related]

  • 18. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.
    Witsch EJ, Peiser M, Hutloff A, Büchner K, Dorner BG, Jonuleit H, Mages HW, Kroczek RA.
    Eur J Immunol; 2002 Sep 15; 32(9):2680-6. PubMed ID: 12207353
    [Abstract] [Full Text] [Related]

  • 19. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX, Jun CY, Yu ZX.
    Haematologica; 2004 Dec 15; 89(12):1517-24. PubMed ID: 15590404
    [Abstract] [Full Text] [Related]

  • 20. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
    Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JG.
    J Exp Med; 2000 Sep 04; 192(5):681-94. PubMed ID: 10974034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.